Literature DB >> 3995186

Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder.

J Rosing, E M Bevers, P Comfurius, H C Hemker, G van Dieijen, H J Weiss, R F Zwaal.   

Abstract

Platelets from a platelet factor 3-deficient patient, which was first described by Weiss et al (Am J Med 67:206, 1979), were found to be equally impaired in their ability to promote factor X and prothrombin activation. Compared to normal platelets, the patient's platelets showed upon stimulation with thrombin plus collagen a much slower generation and a considerably lower level of platelet prothrombin- and factor X-converting activities. Treatment of stimulated platelets with phospholipases revealed a decreased exposure of negatively charged phospholipid at the outer surface of the patient's platelets, relative to control's. We suggest that the combined impairment of prothrombin- and factor X-converting activities in this patient is due to a defect in the mechanism by which phosphatidylserine becomes exposed at the outer surface of stimulated platelets.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3995186

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation.

Authors:  H J Brinkman; P Koster; K Mertens; J A van Mourik
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

2.  Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome.

Authors:  S S Ahmad; R Rawala-Sheikh; B Ashby; P N Walsh
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

3.  The role of the second growth-factor domain of human factor IXa in binding to platelets and in factor-X activation.

Authors:  S S Ahmad; R Rawala; W F Cheung; D W Stafford; P N Walsh
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

Review 4.  Platelet activation in normo- and hyperlipoproteinemias.

Authors:  J Nimpf; H Wurm; G M Kostner; T Kenner
Journal:  Basic Res Cardiol       Date:  1986 Sep-Oct       Impact factor: 17.165

5.  A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties.

Authors:  Xin Huang; Wei-Qun Ding; Joshua L Vaught; Roman F Wolf; James H Morrissey; Roger G Harrison; Stuart E Lind
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

6.  Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects.

Authors:  H J Weiss; V T Turitto; H R Baumgartner
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

7.  Increased expression of procoagulant activity on the surface of human platelets exposed to heavy-metal compounds.

Authors:  C A Goodwin; C P Wheeler-Jones; S Namiranian; S Bokkala; V V Kakkar; K S Authi; M F Scully
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

Review 8.  The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease.

Authors:  Bengt Fadeel; Ding Xue
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Sep-Oct       Impact factor: 8.250

Review 9.  Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance.

Authors:  R F Zwaal; E M Bevers; P Comfurius; J Rosing; R H Tilly; P F Verhallen
Journal:  Mol Cell Biochem       Date:  1989 Nov 23-Dec 19       Impact factor: 3.396

10.  Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome.

Authors:  H Kojima; D Newton-Nash; H J Weiss; J Zhao; P J Sims; T Wiedmer
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.